BridgeMD
New treatment option for Hypersensitivity Pneumonitis
Official title Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis
ClinicalTrials.gov ID: NCT06811389
What this study is testing
- What it's testing
- The central hypothesis is that a peer coach-delivered intervention that includes cognitive behavioral principles combined with theory-driven patient education will improve health-related quality of life (HRQOL) of patients with hypersensitivity pneumonitis (HP). The goal of this behavioral and educational intervention, RISE-HP, is to improve health-related quality of life in people who have hypersensitivity pneumonitis and assess feasibility and accessibility of this intervention.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Have documented diagnosis of Hypersensitivity Pneumonitis by treating clinician.
- Age 18 or older.
- English Speaking.
- Willing to work with a peer coach.
- Have a working smart phone or tablet.
You likely can't join if
- Does not have Hypersensitivity Pneumonitis
- Younger than age 18
- Severe cognitive impairment as determined by their treating physician.
- Participants with severe depression (PHQ-8 score ≥20) will be ineligible for the study and will be referred to alternative sources of care.
- Anyone with documentation in their medical chart of an eating disorder, active substance use disorder, suicidality, homicidality, acute posttraumatic...
- Anyone who is determined to be severely ill or moribund by the treating clinician.
See the full eligibility criteria
- Have documented diagnosis of Hypersensitivity Pneumonitis by treating clinician.
- Age 18 or older.
- English Speaking.
- Willing to work with a peer coach.
- Have a working smart phone or tablet.
- Have access to the internet.
- Reside or live in the United States.
- Endorse verbal approval from treating physician to participate in patients' goal movement/physical activity.
- Meet one or more of the following criteria:
- Baseline score on the PHQ8 of \<20
- Does not have Hypersensitivity Pneumonitis
- Younger than age 18
- Severe cognitive impairment as determined by their treating physician.
- Participants with severe depression (PHQ-8 score ≥20) will be ineligible for the study and will be referred to alternative sources of care.
- Anyone with documentation in their medical chart of an eating disorder, active substance use disorder, suicidality, homicidality, acute posttraumatic stress disorder, or episodes of mania or psychosis.
- Anyone who is determined to be severely ill or moribund by the treating clinician.
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.